Komachi et al. used oral administration of Ki16198 (specific inhibitors of LPAR1 and LPAR3) in nude mice modeled with pancreatic cancer cells, which inhibited tumor growth and reduced invasion and metastasis of other organs 83. This evidence concerns the gene LPAR1 and familial pancreatic carcinoma.